The graft versus host disease treatment market is expanding, fueled by new immunosuppressive agents, biologics, and advanced cell therapies such as mesenchymal stem cells and CAR-T treatments for steroid-resistant GVHD. https://www.datamintelligence.com/research-report/graft-versus-host-disease-treatment-market